Information Library
Case Studies - Oncology
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
Chemotherapy launch in the US
September 23, 2009
This major pharma company managed to meet all its market milestones thanks to a comprehensive fast track education program in toxicity management - spanning medical and radiation oncology nurses and infusion centre personnel. -
Oncology Product Launch – Nurse Educators Surpass Demanding Fast-Track Goals
August 27, 2009
Learn how Innovex worked with a large pharma company to recruit, train and deploy a team of highly qualified Oncology Nurse Educators in just five weeks – to underpin a very demanding launch. -
Metastatic Recurrent Head and Neck Cancer
July 9, 2009
Study drug plus platinum-based chemotherapy in treatment of squamous cell carcinoma of the head and neck (SCCHN) -
Advanced Gastric Cancer
May 12, 2009
To meet the challenges in patient recruitment, Quintiles relied on its therapeutic experience and extensive global site network to select the study sites most likely to treat patients meeting study entry criteria. In order to assist oncologists in working with the primary-tumor-related inclusion criteria, CRAs provided training to all sites based on a radiological briefing document. -
Prostate Cancer Case Study
March 27, 2009
A multi-center phase III randomized trial comparing Drug X in combination with prednisone to mitoxantrone and prednisone for advanced hormone refractory prostate cancer -
Small Cell Lung Cancer
March 27, 2009
A randomized, double-blind, placebo controlled, multi-center, phase III study of Drug X plus chemotherapy (cisplatin and gemcitabine) versus chemotherapy alone in patients with advanced (stage IIIB or IV)non-small cell lung cancer (NSCLC) that have not received prior chemotherapy -
Non-Myeloid Malignancy
March 27, 2009
A randomized, double-blind, active-controlled study of Drug X for the treatment of anemia in subjects with non-myeloid malignancy receiving multi-cycle chemotherapy -
Metastatic Breast Cancer
March 27, 2009
A randomized, controlled, open-label study of Drug X in combination with Drug Y compared with Y alone as first- and second-line treatment for HER2 positive, hormonereceptor positive metastatic -
Colon Cancer
March 27, 2009
A randomized, open-label phase III study comparing Drug X with i.v. bolus 5- fluorouracil in combination with low-dose leucovorin as adjuvant chemotherapy in colon cancer patients with Dukes C tumors -
Pancreatic Cancer Expertise
March 20, 2009
Quintiles’ experience with all types of oncology trials is extensive – but it was their specific experience with pancreatic cancer that helped a major pharmaceutical company out of a very difficult situation.
Page 1 of 1 (10 items)